Gastrointestinal Therapeutics Market to Reach $64.5 Billion, Globally, by 2032 at 5.0% CAGR: Allied Market Research
September 07, 2023 06:39 ET
|
Allied Market Research
New Castle, Delaware, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Gastrointestinal Therapeutics Market by Drug Class (Biologics, Proton Pump Inhibitors,...
Global Antacids Market Analysis Report 2022: A $10.5 Billion Industry by 2027 Featuring Pfizer, GlaxoSmithKline, Dr Reddy's, Johnson & Johnson, Bayer, Sanofi, & Abbott Laboratories
February 15, 2023 03:08 ET
|
Research and Markets
Dublin, Feb. 15, 2023 (GLOBE NEWSWIRE) -- The "Antacids Market, Size, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been added to ...
Global $3.97 Billion Antacids Markets, 2015-2020, 2020-2025F, 2030F
June 30, 2021 04:08 ET
|
Research and Markets
Dublin, June 30, 2021 (GLOBE NEWSWIRE) -- The "Antacids Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. Major players in...
Global Antacids Market (2021 to 2026) - by Drug Class, Formulation, Distribution Channel and Geography
June 25, 2021 05:48 ET
|
Research and Markets
Dublin, June 25, 2021 (GLOBE NEWSWIRE) -- The "Global Antacids Market (2021-2026), by Drug Class, Formulation, Distribution Channel, Geography and the Impact of COVID-19 with Ansoff Analysis" report...
Global $11.66 Billion Antacid Market Forecast to 2027: Market Opportunities in Increasing Research Activities and Research Funds on GI Disorders
February 08, 2021 04:53 ET
|
Research and Markets
Dublin, Feb. 08, 2021 (GLOBE NEWSWIRE) -- The "Antacid Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Dosage Form (Tablet, Liquid, Others); Drug Class (Proton pump inhibitors, H2...